6-Shogaol Abrogates Parkinson's Disease in Rotenone-Induced Rodents: Based on In Silico Study and Inhibiting TNF-α/NF-κB/IL-1β/MAO-B
<b>Background/Objectives:</b> 6-Shogaol is a comparatively innovative anti-Parkinson's remedy with antioxidant and anti-inflammatory characteristics. This investigation intended to determine the role of 6-shogaol in the Parkinson's disease (PD) paradigm in rotenone-induced rats...
Saved in:
Main Authors: | Misbahuddin Rafeeq (Author), Fahad A. Al-Abbasi (Author), Muhammad Afzal (Author), Ehssan Moglad (Author), Salwa D. Al-Qahtani (Author), Sami I. Alzrea (Author), Naif A. R. Almalki (Author), Faisal Imam (Author), Nadeem Sayyed (Author), Imran Kazmi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress
by: Mohamed H. Elsherbeny, et al.
Published: (2021) -
Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
by: John Paul Maurice Finberg, et al.
Published: (2016) -
Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs
by: Hagenow J, et al.
Published: (2020) -
Hibiscetin attenuates oxidative, nitrative stress and neuroinflammation via suppression of TNF-α signaling in rotenone induced parkinsonism in rats
by: Sami I. Alzarea, et al.
Published: (2022) -
Promising selective MAO-B inhibition by sesamin, a lignan from Zanthoxylum flavum stems
by: Shaymaa M. Mohamed, et al.
Published: (2020)